Faculty Publications

Tolcher AW, Karavasilis V, Hudes G, Quinn D, Ferrari A, Kocak I, Mita A, Buell D, Keating A, Bartels P, Charleston D, DeBono J

YM155, a novel survivin suppressant, demonstrates activity in subjects with hormone refractory prostate cancer (HRPC) previously treated with taxane chemotherapy

Ann Oncol. 2007;18:39.

Abstract